Erlotinib: all 574 studies that test it

Page 2 of 6. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung CancerCompletedNCT00983307Phase 2Results posted
• Erlotinib Study for Myelodysplastic Syndrome (MDS)CompletedNCT00977548Phase 2Results posted
• Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung CancerTerminatedNCT00976677Phase 2Results posted
• Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck CancerCompletedNCT00970502Phase 1/2Results posted
• Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung CancerCompletedNCT00950365Phase 2Results posted
• An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00949910Phase 4Results posted
• A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine TumorsTerminatedNCT00947167Phase 2Results posted
• Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell CarcinomaCompletedNCT00942734Phase 2Results posted
• ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic CancerCompletedNCT00925769Phase 1Results posted
• Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular CarcinomaCompletedNCT00901901Phase 3Results posted
• Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung CancerCompletedNCT00888511Phase 2Results posted
• Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver CancerCompletedNCT00881751Phase 2Results posted
• Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung CancerCompletedNCT00871923Phase 2Results posted
• A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung CancerCompletedNCT00855894Phase 2Results posted
• RAD001 and Erlotinib in Patients With Neuroendocrine TumorsTerminatedNCT00843531Phase 2Results posted
• 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer PatientsTerminatedNCT00841035Phase 2Results posted
• Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast CancerCompletedNCT00834678Phase 1/2Results posted
• Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree CancersTerminatedNCT00832637Phase 2Results posted
• Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00826449Phase 1/2Results posted
• Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic CancerCompletedNCT00810719Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain MetastasisCompletedNCT00800202Phase 2Results posted
• A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.TerminatedNCT00773383Phase 2Results posted
• MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic CancerCompletedNCT00769483Phase 1/2Results posted
• Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic CancerCompletedNCT00761345Phase 1Results posted
• Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or AdenomaCompletedNCT00754494Phase 2Results posted
• A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on ErlotinibTerminatedNCT00750698Phase 2Results posted
• Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck CancerTerminatedNCT00750555Phase 2Results posted
• Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial CancerCompletedNCT00749892Phase 2Results posted
• Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast CancerTerminatedNCT00739063Phase 2Results posted
• Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung CancerTerminatedNCT00738881Phase 3Results posted
• Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic AdenocarcinomaCompletedNCT00735306Phase 1Results posted
• Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT00733746Phase 2Results posted
• Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerCompletedNCT00733408Phase 2Results posted
• Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00720356Phase 2Results posted
• Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00720304Phase 2Results posted
• Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to ErlotinibCompletedNCT00716456Phase 1/2Results posted
• Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00705874Phase 1Results posted
• A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung CancerCompletedNCT00701558Phase 2Results posted
• Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic CancerCompletedNCT00696696Phase 2Results posted
• A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic CancerCompletedNCT00674973Phase 2Results posted
• Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma MultiformeCompletedNCT00672243Phase 2Results posted
• Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)CompletedNCT00671970Phase 2Results posted
• Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00660816Phase 2Results posted
• A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic CancerCompletedNCT00652366Phase 2Results posted
• APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung CancerCompletedNCT00652340Phase 2Results posted
• A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated RashCompletedNCT00642473Phase 2Results posted
• Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerTerminatedNCT00640978Phase 2Results posted
• Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by SurgeryCompletedNCT00633750Phase 2Results posted
• Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLCCompletedNCT00621049Phase 2Results posted
• Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.TerminatedNCT00611715Phase 2Results posted
• Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid TumorsCompletedNCT00611468Phase 1Results posted
• Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on ErlotinibCompletedNCT00609804Phase 2Results posted
• A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.CompletedNCT00605722Phase 2Results posted
• A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal CancerCompletedNCT00603915Phase 2Results posted
• Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00600015Phase 2Results posted
• Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast CancerTerminatedNCT00597597Phase 2Results posted
• A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00596648Phase 1/2Results posted
• Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedNCT00592007Phase 2Results posted
• Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric CardiaCompletedNCT00591123Phase 2Results posted
• Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung CancerCompletedNCT00590902Phase 2Results posted
• A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00585533Phase 2Results posted
• Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung CancerCompletedNCT00585377Phase 2Results posted
• Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)CompletedNCT00577707Phase 2Results posted
• Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck CancerTerminatedNCT00573989Phase 1/2Results posted
• Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal TherapyTerminatedNCT00570258Phase 2Results posted
• UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck CancerCompletedNCT00570232Phase 2Results posted
• Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFRCompletedNCT00567359Phase 2Results posted
• TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00563784Phase 2Results posted
• A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00556712Phase 3Results posted
• A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00556322Phase 3Results posted
• Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00553800Phase 2Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00553462Phase 2Results posted
• Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00550537Phase 2Results posted
• A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerCompletedNCT00550173Phase 2Results posted
• Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00547105Phase 2Results posted
• Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by SurgeryTerminatedNCT00539617Phase 2Results posted
• Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract CarcinomasTerminatedNCT00532441Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.CompletedNCT00531960Phase 2Results posted
• Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or GliosarcomaCompletedNCT00525525Phase 2Results posted
• Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00524121Phase 2Results posted
• Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian TumorsCompletedNCT00520013Phase 2Results posted
• A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.CompletedNCT00518011Phase 2Results posted
• Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.TerminatedNCT00503971Phase 1/2Results posted
• Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast CancerTerminatedNCT00503841Not applicableResults posted
• Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryTerminatedNCT00482625Phase 2Results posted
• Erlotinib in Women With Squamous Cell Carcinoma of the VulvarCompletedNCT00476476Phase 2Results posted
• Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung CancerCompletedNCT00473083Phase 2Results posted
• Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic CancerTerminatedNCT00470535Phase 2Results posted
• Erlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaCompletedNCT00466687Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and SurvivalCompletedNCT00461708Phase 2Results posted
• A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With ErlotinibCompletedNCT00453362Phase 1/2Results posted
• A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerCompletedNCT00452413Phase 1/2Results posted
• Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck CancerTerminatedNCT00448240Phase 2/3Results posted
• Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00447057Phase 2Results posted
• Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFRCompletedNCT00446225Phase 3Results posted
• S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung CancerCompletedNCT00445848Phase 2Results posted
• Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeCompletedNCT00445588Phase 2Results posted
• Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00442507Phase 2Results posted
• S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaCompletedNCT00436332Phase 2Results posted
• Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00425386Phase 2Results posted

← Erlotinib overview